Site updated at Wednesday, 22 June 2016

Living with Dementia

Psychotic Symptoms

Acadia redesigns study on Parkinson’s psychosis drug

Acadia Pharmaceuticals Inc said it redesigned an ongoing late-stage study on its experimental anti-psychotic drug for Parkinson’s disease patients, and that it plans to conduct an identical study to win regulatory approval.

The redesigned study will include only patients from North America, and will exclude mildly psychotic patients, Acadia CEO Uli Hacksell said at… Acadia redesigns study on Parkinson’s psychosis drug   

Going Home (A short film on Dementia)

memory impairments1 - hormone replacement therapy1 - stroke9 - alzheimer's drugs4 - alzheimers disease triggers1 - sinus issues1 - circumscribed cerebral atrophy1 - alzheimer's prevention1 - degenerationist hypothesis1 - functional imaging1 - abeta peptides1 - cerebrospinal fluid8 - bladder troubles1 - cognitive1 - transcatheter aortic valve implantation2 - national alzheimer's project act1 - delirium8 - physical activity2 - learning1 - movement disorders1 - bradykinesia1 - ucla1 - alzheimer's drug5 - advanced dementia1 - high oestrogen levels1 - end-stage dementia1 - wernicke's disease10 - rigidity1 - parkinson's diagnosis1 - simplicity1 -